Advertisement
Advertisement

BAX

BAX logo

Baxter International Inc.

27.05
USD
Sponsored
+0.10
+0.37%
Aug 13, 15:59 UTC -4
Closed
exchange

Pre-Market

27.11

+0.06
+0.23%

BAX Earnings Reports

Positive Surprise Ratio

BAX beat 34 of 42 last estimates.

81%

Next Report

Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.94B
/
$0.52
Implied change from Q2 26 (Revenue/ EPS)
-0.76%
/
-7.14%
Implied change from Q3 25 (Revenue/ EPS)
+3.62%
/
-24.64%

Baxter International Inc. earnings per share and revenue

On Jul 30, 2026, BAX reported earnings of 0.56 USD per share (EPS) for Q2 26, beating the estimate of 0.36 USD, resulting in a 51.52% surprise. Revenue reached 2.96 billion, compared to an expected 2.82 billion, with a 4.84% difference. The market reacted with a +7.99% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of 0.52 USD, with revenue projected to reach 2.94 billion USD, implying an decrease of -7.14% EPS, and decrease of -0.76% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.16
Actual
$0.20
Surprise
+24.07%
logo
Omeros Corporation
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.27
Actual
$0.02
Surprise
+107.31%
logo
Brainsway Ltd. - ADR
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.15
Actual
$0.14
Surprise
-7.65%
logo
Valneva SE - ADR
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.34
Surprise
-243.33%
logo
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
logo
Capricor Therapeutics Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.70
Surprise
-16.32%
logo
Organigram Global Inc. Common Shares
Report Date
Aug 11, 2026 For Q3 26
Estimate
$0.00
Actual
-$0.06
Surprise
-2,480.74%
logo
Immucell Corp
Report Date
Aug 13, 2026 For Q2 26
Estimate
-
Actual
$0.20
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.19
Actual
$0.20
Surprise
+0.55%
logo
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
FAQ
For Q2 2026, Baxter International Inc. reported EPS of $0.56, beating estimates by 51.52%, and revenue of $2.96B, 4.84% above expectations.
The stock price moved up 7.99%, changed from $24.77 before the earnings release to $26.75 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on 11 analysts, Baxter International Inc. is expected to report EPS of $0.52 and revenue of $2.94B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement